Clario and AWS Team Up to Revolutionize Clinical Data Analysis Using Generative AI Technology

Clario Partners with AWS for Innovative Clinical Data Solutions

In a significant move for the clinical trial industry, Clario, a prominent provider of endpoint data solutions, has announced a multi-year partnership with Amazon Web Services (AWS). This collaboration aims to enhance the capabilities of Clario's generative AI platform, facilitating improved processing of clinical trial data and documents.

Advancements in Clinical Trials

The core of this collaboration lies in integrating AWS’s advanced AI and machine learning technologies into Clario's existing framework. By utilizing AWS’s robust infrastructure, Clario seeks to decrease the time it takes to initiate clinical trials, thereby speeding up the overall drug development process. Jay Ferro, Clario’s Chief Information, Technology and Product Officer, asserts that this partnership represents a pivotal advancement in Clario’s mission to streamline operations and ensure the delivery of high-quality, regulatory-grade data at an accelerated pace.

"Our collaboration with AWS represents a pivotal step forward in Clario's mission to streamline operations and deliver regulatory-grade data faster," Ferro stated, highlighting the advantages of using AI to alleviate operational difficulties while enhancing data accuracy which leads to better compliance and patient outcomes.

Transforming Data into Actionable Insights

Clario is dedicated to utilizing AI technologies to assist its clients in adapting to the rapidly changing clinical trial landscape. By leveraging AWS’s capabilities, the company is working on the development of a comprehensive multi-modal data analysis pipeline. This innovative approach uses Clario’s proprietary generative AI platform, which orchestrates multiple large language models and deep learning techniques to process vast amounts of unstructured clinical data.

The use of this scalable system allows Clario to transform extensive volumes of unstructured information into actionable insights, which can significantly empower life sciences companies in their innovation efforts. With capabilities in health imaging, cardiac safety, electronic clinical outcome assessments (eCOA), and more, Clario is positioned to optimize the clinical trial process further.

Fostering a Culture of Innovation

As healthcare and life sciences organizations navigate an increasingly complex regulatory environment, Clario is committed to assembling the technological tools necessary for success. The partnership with AWS allows Clario not only to refine its operational processes but also to maintain the highest standards of quality and compliance through innovative technology use.

Marko Topalovic, Clario’s Chief AI Officer, remarks, “AI, and specifically generative AI, is a game changer for our industry.” This reflects a broader trend within the sector toward leveraging emerging technologies to enhance operational efficiency. With an iterative approach to model development, Clario aims to create tailored solutions that address the unique challenges faced by clinical trials.

Looking Ahead

As the partnership matures, Clario aims to continually explore new frontiers in clinical data analysis. With the power of AWS behind them, they’re excited about the potential of advanced technologies to transform the landscape of drug development. Allyson Fryhoff, Managing Director of AWS for Healthcare and Life Sciences, emphasizes the opportunity presented by such collaborations, noting that they will enable sponsors to streamline the process of getting effective therapies to patients faster than ever before.

Clario’s journey with AWS is not just about enhancing efficiency; it is about making strides toward impactful patient care through cutting-edge solutions. The future of clinical trials is set to be transformed, and Clario is resolutely at the forefront of this evolution, committed to shaping the next generation of clinical trial processes effectively.

For more details about this game-changing collaboration, interested parties can explore the AWS Architecture Blog, co-authored by Clario's Director of AI and an AWS Principal Solutions Architect.

About Clario

For over 50 years, Clario has been a leader in the provision of endpoint data solutions, enabling the generation of high-quality clinical evidence for life sciences companies globally. Their contributions have supported over 26,000 clinical trials across more than 100 countries, proving their commitment to the advancement of clinical research. To learn more about Clario’s innovative solutions, visit Clario.com.